Genomic profiling of the tumor in CRC and it clinical use

被引：0
作者：
Hubert, Ayala [1 ]
机构：
[1] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
来源：
TUMOR BIOLOGY | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] Utility of tumor genomic profiling in guiding targeted therapy and referral for clinical trials in the community practice.
    Xu, Yiqing
    Yio, Jiang
    Yang, Amber
    Bayewitz, Ashrei
    Benasher, Daniel
    Fu, Lung
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Single-cell genomic profiling of acute myeloid leukemia for clinical use: A pilot study
    Yan, Benedict
    Hu, Yongli
    Ban, Kenneth H. K.
    Tiang, Zenia
    Ng, Christopher
    Lee, Joanne
    Tan, Wilson
    Chiu, Lily
    Tan, Tin Wee
    Seah, Elaine
    Ng, Chin Hin
    Chng, Wee-Joo
    Foo, Roger
    ONCOLOGY LETTERS, 2017, 13 (03) : 1625 - 1630
  • [43] ROUTINE USE OF COMPREHENSIVE GENOMIC PROFILING TO ASSESS TUMOR MUTATIONAL BURDEN ACROSS A COMMUNITY HEALTH SYSTEM
    Bifulco, Carlo
    Weerasinghe, Roshanthi
    Bapat, Bela
    Dowdell, Alexa
    Pindikuri, Shwetha
    Reynolds, Sheila
    Biery, Nancy
    Ball, David
    Campbell, Mary
    Ward, Thomas
    Stein, Alisha
    Schroeder, Brock
    Eberhard, David
    Piening, Brian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A44 - A45
  • [44] Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study
    Shirota, Hidekazu
    Komine, Keigo
    Takahashi, Masanobu
    Takahashi, Shin
    Miyauchi, Eisaku
    Niizuma, Hidetaka
    Tada, Hiroshi
    Shimada, Muneaki
    Niihori, Tetsuya
    Aoki, Yoko
    Sugiyama, Ikuko
    Kawamura, Maako
    Yasuda, Jun
    Suzuki, Shuhei
    Iwaya, Takeshi
    Saito, Motonobu
    Saito, Tsuyoshi
    Shibata, Hiroyuki
    Furukawa, Toru
    Ishioka, Chikashi
    CANCER MEDICINE, 2023, 12 (05): : 6170 - 6181
  • [45] Impact of comprehensive genomic profiling and molecular tumor board decision on clinical outcome of patients with solid tumors
    Ludwig, S.
    Schmid, L.
    Kahraman, A.
    Rechsteiner, M.
    Zoche, M.
    Curioni-Fontecedro, A.
    Siebenhuener, A.
    Dedes, K.
    Kiessling, M.
    Fritsch, R.
    Wicki, A.
    Moch, H.
    Weber, A.
    Britschgi, C.
    SWISS MEDICAL WEEKLY, 2021, 151 : 37 - 37
  • [46] Clinical decisions by the Molecular Tumor Board on comprehensive genomic profiling tests in Japan: A retrospective observational study
    Shirota, Hidekazu
    Komine, Keigo
    Takahashi, Masanobu
    Takahashi, Shin
    Miyauchi, Eisaku
    Niizuma, Hidetaka
    Tada, Hiroshi
    Shimada, Muneaki
    Niihori, Tetsuya
    Aoki, Yoko
    Sugiyama, Ikuko
    Kawamura, Maako
    Yasuda, Jun
    Suzuki, Shuhei
    Iwaya, Takeshi
    Saito, Motonobu
    Saito, Tsuyoshi
    Furukawa, Toru
    Ishioka, Chikashi
    ANNALS OF ONCOLOGY, 2023, 34 : S1402 - S1402
  • [47] Clinical utility of advanced features provided by circulating tumor DNA-based comprehensive genomic profiling
    Kim, Y-G.
    Ha, C.
    Lim, S. H.
    Hong, J. Y.
    Kim, S. T.
    Sun, J-M.
    Lee, J.
    Kim, J-W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1625 - S1625
  • [48] THE GENETIC LANDSCAPE OF CLINICAL CASES OF PRECURSOR LESIONS OF LATERALLY SPREADING TUMOR VIA COMPREHENSIVE GENOMIC PROFILING
    Wang, Wenjing
    Zhan, Jun
    Zhang, Hejun
    Li, Jun
    Zhang, Jing
    Wang, Ye
    Gu, Fang
    Zhang, Hongquan
    Ding, Shigang
    GASTROENTEROLOGY, 2018, 154 (06) : S276 - S277
  • [49] Deciphering the genomic heterogeneity and evolution in malignant melanoma by genomic profiling of clonal tumor populations
    Lorber, Thomas
    Dietsche, Tanja
    Perrina, Valeria
    Barret, Michael
    Glatz, Kathrin
    Ruiz, Christian
    Bubendorf, Lukas
    CANCER RESEARCH, 2014, 74 (19)
  • [50] Big data in the management of CRC. What is the benefit of extensive genomic analysis of the tumor?
    Wicki, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 101 - 101
12345